Table 2 Antimicrobial use during hospitalization and prior to detection of Clostridium difficile in stool
Antimicrobials | Number of patients (%) N = 78† | Duration of treatment | Duration of treatment |
|---|---|---|---|
Mean (+/− SD) | Median (range) | ||
All Antimicrobials | 59 (75.6%) | 10.8 (11.0) | 7 (1-33) |
Penicillins* | 30 (38.5%) | 4.6 (3.8) | 4 (1-12) |
Cephalosporins** | 23 (29.5%) | 6.8 (31.5) | 6 (1-26) |
Fluoroquinolones*** | 21 (26.9%) | 4.9 (6.6) | 2 (1-12) |
Carbapenems# | 12 (15.4%) | 9.8 (6.5) | 4 (1-21) |
Glycopeptides## | 8 (10.3%) | 5 (8.2) | 2 (1-25) |
Nitroimidazoles### | 4 (5.1%) | 5.8 (4.6) | 5 (1-12) |
Aminoglycosides†† | 3 (3.8%) | 2.7 (1.5) | 3 (1-4) |
Clindamycin | 2 (2.7%) | 4 (1.4) | 4 (3-5) |
Macrolides††† | 1 (1.3%) | 3 (0) | 3 (3) |
Trimethoprim/Sulfamethoxazole | 9 (11.5%) | 4.7 (5.0) | 2 (1-14) |